F.D.A.’s Approval of a Drug for Autism Upends Review Process
NeutralScience

The FDA's recent approval of a new drug for autism has sparked significant discussion about the review process for medications targeting this condition. This approval is noteworthy as it may change how future treatments are evaluated, potentially leading to quicker access for patients. The implications of this decision could reshape the landscape of autism treatment and influence how similar drugs are assessed in the future.
— Curated by the World Pulse Now AI Editorial System